EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An Inhibitory Aptamer Against PDGF-C Overcomes Anti-VEGF Refractoriness and Reduces Choroidal Neovascularization and Fibrosis

Rongyuan Chen, Weiwei Lu, Juanhua Zhu, Lijuan Huang, Wei Chen, Guanqun Huang, Xiangrong Ren, Qihang Sun, Jiaxin Hu, Jiani Li, Shasha Wang, Haiqing Kuang und 17 weitere

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.5.36 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Rongyuan Chen und 28 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University and Guangdong Provincial Key Laboratory of Ophthalmology a…. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Platelet-Derived Growth Factor, Aptamers, Nucleotide, Lymphokines. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Choroidal NeovascularizationPlatelet-Derived Growth FactorAptamers, NucleotideLymphokinesVascular Endothelial Growth Factor AAnimalsFibrosisMiceHumansDisease Models, AnimalAngiogenesis InhibitorsCell ProliferationMice, Inbred C57BLCell MovementCells, CulturedSurface Plasmon ResonanceReceptor, Platelet-Derived Growth Factor alpha

Substanzen

Platelet-Derived Growth FactorAptamers, Nucleotideplatelet-derived growth factor CLymphokinesVascular Endothelial Growth Factor AAngiogenesis InhibitorsReceptor, Platelet-Derived Growth Factor alpha

Autor:innen und Institutionen

  • State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University and Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China.
  • Department of Ophthalmology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China.
  • Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.
  • Genetic Diseases Key Laboratory of Sichuan Province, Center for Medical Genetics, Department of Laboratory Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, School of Medicine, Univ…
  • Affiliated Eye Hospital of Nanjing Medical University, Nanjing, China.
  • Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong, China.

Zitieren

APA

Chen, R., Lu, W., Zhu, J., Huang, L., Chen, W., Huang, G., Ren, X., Sun, Q., Hu, J., Li, J., Wang, S., Kuang, H., Lee, C., Lu, W., Xiong, Z., Liu, Y., Wang, X., Prodeus, A., Zhu, X., …, & Li, X. (2026). An Inhibitory Aptamer Against PDGF-C Overcomes Anti-VEGF Refractoriness and Reduces Choroidal Neovascularization and Fibrosis. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.5.36

Vancouver

Chen R, Lu W, Zhu J, Huang L, Chen W, Huang G, et al. An Inhibitory Aptamer Against PDGF-C Overcomes Anti-VEGF Refractoriness and Reduces Choroidal Neovascularization and Fibrosis. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.5.36

BibTeX
@article{Chen2026,
  author = {Chen, Rongyuan and Lu, Weiwei and Zhu, Juanhua and Huang, Lijuan and Chen, Wei and Huang, Guanqun and Ren, Xiangrong and Sun, Qihang and Hu, Jiaxin and Li, Jiani and Wang, Shasha and Kuang, Haiqing and Lee, Chunsik and Lu, Weisi and Xiong, Zhen and Liu, Yi and Wang, Xiaolu and Prodeus, Aaron and Zhu, Xianjun and Zhang, Qiuyang and Li, Keran and Deng, Aijun and Cao, Yihai and Yao, Yong and Gariepy, Jean and Liu, Xialin and Yang, Zhenglin and Jiang, Qin and Li, Xuri},
  title = {An Inhibitory Aptamer Against PDGF-C Overcomes Anti-VEGF Refractoriness and Reduces Choroidal Neovascularization and Fibrosis},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.5.36}
}
Kostenlos starten →